It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: c2oden
originally posted by: aethertek
You want to "fix" humanity? Time spent fixing "stupid" would go a long way towards that goal.
And stupid means what?
Somebody who doesn't agree with you.
That is what you post, and is what you are.
originally posted by: kaylaluv
a reply to: continuousThunder
Yep, I think the correct philosophical question should be, if we could wire the brain in utero to guarantee tolerance of others who aren’t harming anyone, should we?
Cleft palate is an actual defect. You said we fix that at birth though. Scientifically speaking, there are only two genders one female one male. However, since our genetic makeup does rule our personality...
originally posted by: JoshuaCox
a reply to: DBCowboy
We fix clef lips at birth.. that’s not life threatening, but it will have a negative societal reaction.. so we fix it..
It is t the clef lip persons fault..
It is society who are mean..
But we still fix them..
Scientists have a strong foundation for their search for personality genes from the years of basic psychology and neuroscience studies that have explored just exactly what personality is and how personality-related behaviors might be influenced by specific neural mechanisms.
originally posted by: feldercarb
Prenatal Dexamethasone for Congenital Adrenal HyperplasiaThis situation has already started.
Following extensive examination of published and unpublished materials, we provide a history of the use of dexamethasone in pregnant women at risk of carrying a female fetus affected by congenital adrenal hyperplasia (CAH). This intervention has been aimed at preventing development of ambiguous genitalia, the urogenital sinus, tomboyism, and lesbianism.
If you will note this paper was written in 2012. This situation has been going on for awhile.
In the United States, the use of prenatal dexamethasone remains “off-label.” This means that the indication has never received approval by the Food and Drug Administration (FDA).1 Nonetheless, we want to be clear: The problem we see with the use of prenatal dexamethasone for CAH is not per se that it is an off-label use; it is rather that—as this paper documents—prenatal dexamethasone for CAH has sometimes been promoted to prospective patients and clinicians in misleading ways, and sometimes promoted for uses that are not legitimately medical (e.g., for the prevention of tomboyism and lesbianism). Furthermore, this intervention—intended to alter the course of fetal development—has been “studied” in ways so slipshod as to breach professional standards of medical ethics.
Late in 2009, clinicians working in the pediatric care of children born with sex anomalies made one of us (Dreger) aware of their growing alarm about prenatal dexamethasone for CAH. These clinicians were concerned that pregnant women at risk for having daughters with CAH were being given prenatal dexamethasone without being informed that (a) this use has consistently been labeled experimental by expert panels;